Evaluation of the ReNu™ Amniotic Suspension Allograft After Marrow Stimulation in the Treatment of Osteochondral Defects
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 08 Jun 2017 Planned End Date changed from 1 Jun 2019 to 1 Oct 2019.
- 08 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2018.
- 03 Feb 2017 New trial record